The Portuguese government will decide next week whether to replace or reappoint Bank of Portugal Governor Mario Centeno, ...

Announced M&A in EMEA rose 16% in the six months to June but FIG dealmaking surged 48% to $85bn. That made it the busiest ...

In December 2024, Lone Star and Bank of Portugal entered into an agreement regarding the payment of dividends by Novo Banco, which are a mandatory requirement for an IPO. In particular, Novo Banco is ...

Novo Banco is a large Portuguese financial bank with headquarters in Lisbon (Portugal). Since 2014, the bank has been under the supervision of the European Central Bank in accordance with banking ...

Disgraced art empresario Joe Berardo charged with aggravated fraud; Berardo and three others accused of ‘simulating civil ...

A key factor in this process is the position of the Portuguese government. The Portuguese authorities expressed their “displeasure” at the possibility of Caixabank, already with a significant presence ...

Link Securities | Caixabank (CABK) is considering a takeover bid for Portuguese bank Novo Banco. There are other interested entities, such as the French group BPCE and the Portuguese Caixa Geral de ...

The Banco Espírito Santo S.A.-Bond has a maturity date of 1/2/2043 and offers a coupon of 3.5000%. The payment of the coupon will take place 1,0 times per Year on the 02.01.. At the current price ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

June 26 (Reuters) - Novo Nordisk (NOVOb.CO) said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

Hims & Hers stock fell 35% after Novo Nordisk ended their partnership on Monday. Novo Nordisk stopped the deal because Hims sold a cheaper version of Wegovy.

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the U.S. company is using 'deceptive marketing' to sell copycat versions of its obesity ...